Table 5.
Outcome | P value |
---|---|
Arthralgia | 0.390 |
Bone pain | 0.608 |
Back pain | 0.744 |
Pain in extremity | 0.056 |
Myalgia | 0.794 |
LS BMD 12 months (normal at baseline-ZOL trials) | 0.0003 |
LS BMD 12 months (osteopenic at baseline-ZOL trials) | 0.296 |
LS BMD 12 months (residronate and ibandronate trials) | 0.345 |